-
Publication Venue For
-
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial.
2023
-
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial..
28:2504-2511.
2022
-
Ensuring remote diagnostics for pathologists: an open letter to the US Congress..
28:2453-2455.
2022
-
Fixing America's eating habits with effective stakeholder collaborations..
28:2469-2470.
2022
-
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial..
28:2388-2397.
2022
-
Author Correction: Diversity, equity and inclusion actions from the NCATS Clinical and Translational Science awarded programs..
28:2217.
2022
-
Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial..
28:2183-2193.
2022
-
Publisher Correction: State-dependent responses to intracranial brain stimulation in a patient with depression..
28:2218.
2022
-
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER..
28:1956-1964.
2022
-
Diversity, equity and inclusion actions from the NCATS Clinical and Translational Science awarded programs..
28:1730-1731.
2022
-
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition..
28:1924-1932.
2022
-
Large-scale genome-wide association study of coronary artery disease in genetically diverse populations..
28:1679-1692.
2022
-
Syndemics and clinical science..
28:1359-1362.
2022
-
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial..
28:1288-1296.
2022
-
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial..
28:1042-1049.
2022
-
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial..
28:1022-1030.
2022
-
Boosting immunity to Omicron..
28:445-446.
2022
-
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial..
28:568-574.
2022
-
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy..
27:1893-1898.
2021
-
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis..
27:2025-2031.
2021
-
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018..
27:1761-1782.
2021
-
Closed-loop neuromodulation in an individual with treatment-resistant depression..
27:1696-1700.
2021
-
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial..
27:1718-1724.
2021
-
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial..
27:1410-1418.
2021
-
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19..
27:668-676.
2021
-
Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment..
27:586-588.
2021
-
Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics..
27:546-559.
2021
-
State-dependent responses to intracranial brain stimulation in a patient with depression..
27:229-231.
2021
-
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial..
27:106-114.
2021
-
Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome..
26:1912-1918.
2020
-
Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017..
26:1308.
2020
-
Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer..
26:982.
2020
-
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers..
26:932-940.
2020
-
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia..
26:760-768.
2020
-
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017..
26:750-759.
2020
-
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes..
26:681-687.
2020
-
Viable bacterial colonization is highly limited in the human intestine in utero..
26:599-607.
2020
-
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis..
25:1243-1250.
2019
-
Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults..
25:569-574.
2019
-
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer..
25:628-640.
2019
-
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors..
25:529.
2019
-
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy..
25:427-432.
2019
-
Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite..
25:188-189.
2019
-
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals..
24:1701-1707.
2018
-
Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells..
24:1536-1544.
2018
-
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV..
24:1590-1598.
2018
-
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors..
24:1459-1468.
2018
-
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1..
24:857-867.
2018
-
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition..
24:847-856.
2018
-
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite..
24:408-416.
2018
-
AI for medical imaging goes deep..
24:539-540.
2018
-
Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis..
24:617-627.
2018
-
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms..
24:165-175.
2018
-
Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models..
24:194-202.
2018
-
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function..
24:39-49.
2018
-
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis..
23:1362-1368.
2017
-
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors..
23:1046-1054.
2017
-
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4..
23:1063-1071.
2017
-
HDAC3 sets the timer on muscle fuel switching..
23:148-150.
2017
-
Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome..
23:213-222.
2017
-
Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms..
23:91-99.
2017
-
Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling..
22:1475-1481.
2016
-
Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain..
22:1465-1469.
2016
-
Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition..
22:1192.
2016
-
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy..
22:1131-1139.
2016
-
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition..
22:762-770.
2016
-
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation..
22:632-640.
2016
-
PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically..
22:37-45.
2016
-
TCF1 links GIPR signaling to the control of beta cell function and survival..
22:84-90.
2016
-
Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade..
21:1326-1331.
2015
-
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases..
21:1018-1027.
2015
-
Breaking bad blood: β2-microglobulin as a pro-aging factor in blood..
21:844-845.
2015
-
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes..
21:449-456.
2015
-
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers..
21:231-238.
2015
-
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents..
21:27-36.
2015
-
A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer..
20:1340-1347.
2014
-
Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia..
20:1090-1091.
2014
-
Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia..
20:624-632.
2014
-
Lessons from babies: inducing HIV-1 broadly neutralizing antibodies..
20:583-585.
2014
-
Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis..
20:664-669.
2014
-
Straight talk with...Victor Dzau. Interview by Roxanne Khamsi..
20:325.
2014
-
Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression..
20:360-367.
2014
-
Dopamine mediates vagal modulation of the immune system by electroacupuncture..
20:291-295.
2014
-
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction..
19:1273-1280.
2013
-
Toward better representations of sound with cochlear implants..
19:1245-1248.
2013
-
Tracking adipogenesis during white adipose tissue development, expansion and regeneration..
19:1338-1344.
2013
-
Regulation of hepatic innate immunity by hepatitis C virus..
19:879-888.
2013
-
Epidermal growth factor regulates hematopoietic regeneration after radiation injury..
19:295-304.
2013
-
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy..
18:1835-1840.
2012
-
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines..
18:1673-1681.
2012
-
Neighborhood watch orchestrates liver regeneration..
18:497-499.
2012
-
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity..
18:595-599.
2012
-
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer..
18:521-528.
2012
-
Under pressure: the search for the essential mechanisms of hypertension..
17:1402-1409.
2011
-
Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells..
17:1298-1303.
2011
-
Lung stem cells: looking beyond the hype..
17:788-789.
2011
-
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy..
17:860-866.
2011
-
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition..
17:875-882.
2011
-
Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex..
17:822-829.
2011
-
Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death..
17:692-699.
2011
-
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies..
17:610-617.
2011
-
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance..
16:1414-1420.
2010
-
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease..
16:998-1000.
2010
-
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma..
16:793-798.
2010
-
Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions..
16:592-597.
2010
-
Getting biological about the genetics of diabetes..
16:388-391.
2010
-
Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells..
16:475-482.
2010
-
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys..
16:324-328.
2010
-
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor..
16:205-213.
2010
-
Modulating hedgehog signaling can attenuate the severity of osteoarthritis..
15:1421-1425.
2009
-
Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines..
15:1259-1265.
2009
-
CCL3L1 and HIV/AIDS susceptibility..
15:1110-1112.
2009
-
Development of universal antidotes to control aptamer activity..
15:1224-1228.
2009
-
Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates..
15:746-749.
2009
-
The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases..
15:177-184.
2009
-
Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis..
14:1343-1350.
2008
-
SNO-hemoglobin and hypoxic vasodilation..
14:1008-1009.
2008
-
Mast cell activators: a new class of highly effective vaccine adjuvants..
14:536-541.
2008
-
Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain..
14:331-336.
2008
-
Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation..
14:306-314.
2008
-
Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone..
14:181-187.
2008
-
Oxidative damage-induced inflammation initiates age-related macular degeneration..
14:194-198.
2008
-
Retraction: Genomic signatures to guide the use of chemotherapeutics..
17:135.
2011